RYLPF (Koninklijke Philips NV) Long-Term Debt: $7,966 Mil (As of Mar. 2026)


RYLPF Koninklijke Philips NV RYLPF
70 GF Score
Price $28.01
GF Value $26.00
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Koninklijke Philips NV Long-Term Debt?

Koninklijke Philips NV RYLPF +2.21% 70 Long-Term Debt is $7,966 Mil as of Mar. 2026. GuruFocus rates RYLPF with a GF Score™ of 70/100 and a GF Value™ of $26.00 (Fairly Valued). The stock has 3 warning signs investors should review.

Koninklijke Philips NV's Long-Term Debt for the quarter that ended in Mar. 2026 was $7,966 Mil.

Koninklijke Philips NV's quarterly Long-Term Debt declined from Sep. 2025 ($8,494 Mil) to Dec. 2025 ($7,089 Mil) but then increased from Dec. 2025 ($7,089 Mil) to Mar. 2026 ($7,966 Mil).

Koninklijke Philips NV's annual Long-Term Debt declined from Dec. 2023 ($6,647 Mil) to Dec. 2024 ($6,486 Mil) but then increased from Dec. 2024 ($6,486 Mil) to Dec. 2025 ($7,089 Mil).

Koninklijke Philips NV  (OTCPK:RYLPF) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Koninklijke Philips NV Long-Term Debt Related Terms

Koninklijke Philips NV Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Koninklijke Philips NV's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Koninklijke Philips NV Long-Term Debt Chart

Koninklijke Philips NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,394.35 6,530.72 6,646.67 6,485.86 7,088.99

Koninklijke Philips NV Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7,628.11 8,283.74 8,494.13 7,088.99 7,966.47
RYLPF
70GF Score
Koninklijke Philips NV RYLPF
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $7,966 Mil mean?
Koninklijke Philips NV (RYLPF) has a Long-Term Debt of $7,966 Mil as of Mar. 2026.
Is Koninklijke Philips NV's Long-Term Debt too high?
Koninklijke Philips NV's current Long-Term Debt is $7,966 Mil. Overall, Koninklijke Philips NV has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Koninklijke Philips NV's Long-Term Debt compare to ABT and SYK?
Koninklijke Philips NV's Long-Term Debt of $7,966 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Devices & Instruments company?
A good Long-Term Debt depends on the Medical Devices & Instruments industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Koninklijke Philips NV's current Long-Term Debt is $7,966 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Koninklijke Philips NV stock overvalued right now?
Based on GuruFocus' analysis, Koninklijke Philips NV (RYLPF) is currently considered Fairly Valued. The stock's GF Value™ is $26.00, compared to a current price of $28.01 — trading 7.7% above its estimated fair value. The current Long-Term Debt is $7,966 Mil. Koninklijke Philips NV's overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Koninklijke Philips NV (RYLPF), the current Long-Term Debt is $7,966 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Koninklijke Philips NV (RYLPF) Overvalued in 2026?

Based on GuruFocus' analysis, Koninklijke Philips NV stock appears to be overvalued. The current stock price of $28.01 is trading 7.7% above its estimated GF Value™ of $26.00. GuruFocus considers Koninklijke Philips NV to be Fairly Valued.

Key valuation signals for RYLPF:

  • Long-Term Debt: $7,966 Mil
  • GF Value™: $26.00 vs. price of $28.01 (7.7% above fair value)
  • GF Score™: 70/100 with 3 warning signs

No single metric tells the full story. See the RYLPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Koninklijke Philips NV Business Description

Address Prinses Irenestraat 59, Amsterdam, NLD, 1077 WV
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound and X-ray equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.
70GF Score

Get the complete analysis for RYLPF

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$28.01
Price
$26.00
GF Value